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Prigger Activity More Than Three Years After
eft Atrial Linear Ablation Without Pulmonary
ein Isolation in Patients With Atrial Fibrillation
ildegard Tanner, MD, Gerhard Hindricks, MD, Richard Kobza, MD, Anja Dorszewski, MD,
etra Schirdewahn, MD, Christopher Piorkowski, MD, Jin-Hong Gerds-Li, MD, Hans Kottkamp, MD
eipzig, Germany
OBJECTIVES The aim of this study was to analyze trigger activity in the long-term follow-up after left atrial
(LA) linear ablation.
BACKGROUND Interventional strategies for curative treatment of atrial fibrillation (AF) are targeted at the
triggers and/or the maintaining substrate. After substrate modification using nonisolating
linear lesions, the activity of triggers is unknown.
METHODS With the LA linear lesion concept, 129 patients were treated using intraoperative ablation
with minimal invasive surgical techniques. Contiguous radiofrequency energy-induced lesion
lines involving the mitral annulus and the orifices of the pulmonary veins without isolation
were placed under direct vision.
RESULTS After a mean follow-up of 3.6  0.4 years, atrial ectopy, atrial runs, and reoccurrence of AF
episodes were analyzed by digital 7-day electrocardiograms in 30 patients. Atrial ectopy was
present in all patients. Atrial runs were present in 25 of 30 patients (83%), with a median
number of 9 runs per patient/week (range 1 to 321) and a median duration of 1.2 s/run (range
0.7 to 25), without a significant difference in atrial ectopy and atrial runs between patients
with former paroxysmal (n 17) or persistent AF (n 13). Overall, 87% of all patients were
completely free from AF without antiarrhythmic drugs.
CONCLUSIONS A detailed rhythm analysis late after specific LA linear lesion ablation shows that trigger
activity remains relatively frequent but short and does not induce AF episodes in most
patients. The long-term success rate of this concept is high in patients with paroxysmal or
persistent AF. (J Am Coll Cardiol 2005;46:338–43) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.03.063Cardiology Foundation
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por curative treatment of atrial fibrillation (AF), the initi-
ting triggers and the perpetuating substrate are the main
argets for interventional ablation strategies (1–6). A spe-
ific left atrial (LA) linear lesion concept targeting the
erpetuation of AF and therefore modifying the substrate
as tested using intraoperative ablation with minimally
nvasive surgical techniques in the Intraoperative Radiofre-
uency Ablation of Atrial Fibrillation (IRAAF) study (7,8).
n that study, contiguous radiofrequency (RF) energy-
nduced lesion lines involving the mitral annulus (MA) and
he orifices of the pulmonary veins (PV) were placed under
irect vision to prevent anatomically defined LA re-entrant
ircuits. No PV isolation, surgical mass reduction, or right
trial lesions were performed.
After substrate modification using nonisolating linear
esion lines, the activity of initiating triggers is unknown.
herefore, the aim of the present study was to analyze
rigger activity in the IRAAF population, i.e., premature
trial complexes (PAC) and, in particular, atrial runs, and
eoccurrence of AF episodes in these patients during long-
erm follow-up more than three years after the ablation
rocedure.
From the University of Leipzig, Heart Center, Cardiology, Department of
lectrophysiology, Leipzig, Germany. Dr. Tanner was supported by a grant from the
wiss Foundation for Pacemaker and Electrophysiology.a
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tudy population. Of 129 patients treated for paroxysmal
nd persistent AF with intraoperative RF ablation as a
rimary indication for operation using minimally invasive
urgical techniques through a right lateral mini-
horacotomy, 30 consecutive patients (27 men, 3 women,
ean age 55  11 years) reaching a follow-up of at least 3
ears were included in the present analysis (Table 1).
eventeen patients (57%) originally had paroxysmal AF and
3 (43%) persistent AF with an AF history of 8  6 years
range 1 to 25 years). All patients were highly symptomatic
efore ablation despite multiple antiarrhythmic drug regi-
ens including class I and III antiarrhythmic drugs. All
atients with paroxysmal AF had two or more AF episodes
er week lasting 12 h.
Lone AF was present in 19 patients (64%), 7 (23%) had
history of arterial hypertension, and 4 (13%) had a history
f myocarditis and/or pericarditis. No patient had coronary
rtery disease or valvular heart disease as assessed with
oronary angiography or transthoracic or transesophageal
chocardiography.
Five patients had a total of six ablation procedures before
tudy entry: two patients had conventional ablation of the
avo-tricuspid isthmus because of typical atrial flutter, two
atients had Lasso-guided PV isolation with AF recurrence,
nd one patient had both procedures. The institutional
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July 19, 2005:338–43 Trigger Activity Late After Ablation of AFeview committee approved the study, and all patients gave
ritten informed consent to the investigational nature of the
rocedure.
urgical approach and RF catheter ablation. A detailed
escription of the surgical approach and the ablation tech-
ique has been published previously (7,8). Briefly, all
atients were operated on a video-assisted minimally inva-
ive surgical approach via a right anterolateral mini-
horacotomy. The LA was incised parallel to the interatrial
roove anterior to the right PVs, allowing access to the MA
s well as exposure of the orifices of the PVs. Radiofre-
uency alternating current (500 kHz, modified HAT 200S;
sypka GmbH, Grenzach-Wyhlen, Germany) was deliv-
red in a unipolar mode between the 10-mm T-shaped tip
lectrode of a specially designed ablation probe (Osypka
mbH) and a 10  16 cm external backplate electrode. A
rawing of the LA with the RF energy-induced LA linear
esions is given in Figure 1. The first lesion line extended
rom the left inferior aspect of the MA to the left PVs. The
econd line connected the left lower and upper PV orifices.
rom there, a third line coupled the left and right upper
Vs. Then the right upper and lower PV orifices were
onnected. Finally, the line at the LA roof was connected to
he surgical incision to prevent “incisional re-entry.”
ostoperative management and follow-up. Daily 12-lead
lectrocardiograms (ECGs) and two 24-h ECGs were
erformed within the first 10 postoperative days. In case of
arly recurrences of AF, electrical cardioversion and insti-
Abbreviations and Acronyms
AF  atrial fibrillation
ECG  electrocardiogram
IRAAF  Intraoperative Radiofrequency Ablation of
Atrial Fibrillation
LA  left atrium/atrial
MA  mitral annulus
PAC  premature atrial complex
PV  pulmonary vein
RF  radiofrequency
able 1. Clinical Characteristics of the Study Patients (n  30)
ge, yrs 55  11
en, n (%) 27 (90)
F history, yrs 7.9  6.0
rterial hypertension, n (%) 7 (23)
istory of myocarditis/pericarditis, n (%) 4 (13)
oronary artery disease, n (%) 0 (0)
alvular heart disease or CM, n (%) 0 (0)
aroxysmal AF, n (%) 17 (57)
ersistent AF, n (%) 13 (43)
one AF, n (%) 19 (64)
eft atrial diameter, mm 43  5
V ejection fraction, % 60  7
o prior ablation attempt, n (%) 25 (83)
rior AF ablation, n (%) 3 (10)
rior atrial flutter ablation, n (%) 3 (10)
uration of follow-up, yrs 3.6  0.4PF  atrial fibrillation; CM  cardiomyopathy; LV  left ventricular.ution of an antiarrhythmic drug treatment (class Ic or
miodarone) were followed. According to the study proto-
ol, antiarrhythmic drug treatment was withdrawn three
onths after the operation. All patients were seen in the
utpatient clinic at six weeks, three months, six months, one
ear, two years, and three years after the procedure. A
2-lead ECG, 24-h ECG, and echocardiography were
erformed in all patients during each follow-up visit.
In two-thirds of the patients with persistent and in
ne-third of the patients with paroxysmal AF, transient
ecurrences of AF were observed in the early postoperative
eriod (8). However, these early relapses of AF directly after
peration did not predict long-term treatment outcome, and
reedom from AF after 12 months measured 90%.
For the present study, in all patients reaching a follow-up
f at least three years, a continuous digital seven-day ECG
Lifecard CF; DelmarReynolds Medical, Inc., Irvine, Cal-
fornia) was recorded. One patient was excluded from
nalysis because of the presence of a dual-chamber pace-
aker because of sick sinus syndrome with permanent atrial
timulation.
Detailed rhythm analysis was done by the means of the
even-day ECG recordings. As surrogate for trigger
ctivity, PAC and atrial runs (3 beats up to 30 s) were
ounted. Frequent PACs were defined as 100
igure 1. Drawing of the left atrium (LA) in a postero-anterior view with
he radiofrequency energy-induced left atrial linear lesions (dense black
ines) for treatment of atrial fibrillation. The first line extended from the
itral annulus (MA) to the left lower pulmonary vein (LLPV). The second
ine connected the LLPV and the left upper pulmonary vein (LUPV)
rifices. From there, a third line coupled the left and the right pulmonary
eins. Then the right upper pulmonary vein (RUPV) and right lower
ulmonary vein (RLPV) orifices were connected. Care was taken to
dvance the tip of the ablation probe only a few millimeters inside the
unnel-shaped parts of the pulmonary veins. Finally, the line at the LA roof
as connected to the surgical incision to prevent “incisional re-entry.” The
otted line indicates the LA incision. IVC  inferior vena cava; LAA 
eft atrial appendage; SVC  superior vena cava.AC per 7-day ECG. The duration and number of
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Trigger Activity Late After Ablation of AF July 19, 2005:338–43entricular contractions resulting from atrial runs were
easured. In addition, a quantitative analysis of all
ecurrent AF episodes (episode lasting more than 30 s)
as performed.
The analysis of the recordings was done by a single
lectrophysiologist. The counting was done manually in the
rst 10 patients because an automatic counting was not
ossible. Thereafter, the data of these patients were ex-
orted to analysis software (Pathfinder, DelmarReynolds
edical Inc., Irvine, California). After analysis by this
oftware, all premature complexes and atrial runs were
hecked again. There was no difference in manually count-
ng and using the software with respect to the number of
trial runs, and the difference with respect to premature
trial contraction was 5% and not significant. Therefore,
he remaining 20 patients received software-assisted count-
ng with manual correction.
Patients were equipped with a symptom log and in-
tructed on how to document duration, quality, and severity
f symptoms during the ECG recording and medical
reatment (i.e., antiarryhthmic drugs, beta-blockade, and
ral anticoagulation therapy). The symptoms (palpitation,
yspnea, dizziness, and chest pain as surrogate of AF) were
ualitatively scored in the symptom log as none, minimal,
ild, moderate, or severe.
tatistical analysis. Continuous variables were expressed
s mean  SD or as median and range when variables were
igure 2. Typical examples of electrocardiogram recordings of rare and fre
), and atrial fibrillation (E) in five different patients.ot normally distributed. sESULTS
fter a mean follow-up of 3.6  0.4 years (range 3.0 to 4.3
ears), 162  10 ECG hours per patient (range 131 to
68 h) were recorded and analyzed. Typical examples of
CG recordings of rare and frequent PACs, short and long
trial runs, and AF in five different patients are given in
igure 2.
Overall, 29 of 30 patients (97%) did not receive any
ntiarrhythmic drugs; 1 patient was treated with amioda-
one. Twenty patients (67%) received beta-blockers and 11
atients (37%) had treatment with an angiotensin-
onverting enzyme inhibitor. Patients were treated with
eta-blockers because of arterial hypertension (n  7), rate
ontrol in case of AF (n  2), and mild symptoms of PACs
nd atrial runs (n  11). No other rate-controlling medi-
ation was used. Two patients (7%) with recurrent AF
eceived oral anticoagulation therapy; nine patients (30%)
ad treatment with aspirin.
uality of recordings. The intention to monitor was seven
ays for all patients. Therefore, the overall duration of the
ssessed single-lead ECG recordings was 5,040 h. From the
ntended 5,040 h of recordings, 4,857 h (96%) were avail-
ble for analysis. More than 3% of the missing data were
ecause of part-time removal of the device by the patient.
ess than 1% of the recordings were excluded from analysis
ecause of artifacts. Patients were equipped with additional
premature atrial complexes (A and B), short and long atrial runs (C andquenturface electrodes in case of insufficient skin contact. In this
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July 19, 2005:338–43 Trigger Activity Late After Ablation of AFase, the patients were alerted by the device. Therefore, the
verall recording quality was excellent.
AC and atrial runs. Premature atrial complexes were
resent in all patients over a wide range (median 240, range
0 to 62,751) (Fig. 3). Premature atrial complexes in
atients with former paroxysmal AF (median 188, range 11
o 32,568) and former persistent AF (median 726, range 10
o 62,751) were comparable. More than 100 PACs per
-day ECG were found in 21 patients (70%). Frequent
ACs in patients with former paroxysmal AF (65%) and in
hose with former persistent AF (77%) were comparable.
trial runs were found in 83% of all patients (n  25).
atients with former paroxysmal AF had slightly more atrial
uns (n  15, 88%) than patients with former persistent AF
n  10, 77%). The median duration of ventricular con-
ractions resulting from atrial runs measured 1.2 s/run
range 0.7 to 25 s) with a median number of 4 beats (range
to 56 beats) per atrial run.
eoccurrence of AF. Overall, 26 of 30 patients (87%) were
ompletely free from AF and 4 patients (13%) had parox-
smal episodes of AF. Two of them were asymptomatic.
hree of these patients had former persistent AF, later
resenting with paroxysmal AF, and one patient had former
aroxysmal AF. No patient presented with persistent AF.
reedom from AF in patients with former paroxysmal AF
as 94% (one patient with antiarrhythmic drug treatment)
nd 77% in patients with former persistent AF (no patients
ith antiarrhythmic drug treatment) (Fig. 4). Directly after
he procedure, freedom from AF measured 53%, after 6
onths 97%, after 1 year 100%, after 2 years 100% as
ssessed with conventional 24-h ECG, and after 3 years
sing 7-day ECGs 87% (Fig. 5).
Altogether, 29 AF episodes were found in the 4 patients
ith recurrent paroxysmal AF. Given the overall number of
,017 atrial runs, 2.8% of these runs resulted in AF (defined
s lasting 30 s). Twenty-six of 29 AF episodes (90%)
asted 2 h, one AF episode (3%) lasted between 2 and
4 h, and only 2 AF episodes (7%) lasted more than 24 h.
n patients with former paroxysmal AF, no episode lasted
ore than 2 h. No episode with atrial flutter was detected.
igure 3. Presence of atrial (AT) runs, frequent (100) premature atrial
omplexes (PAC), and PAC in all patients, and in those with former
aroxysmal (n  17) and persistent (n  13) atrial fibrillation (AF).
uled bars  all patients; dotted bars  paroxysmal AF; black bars 
ersistent AF.The definition of recurrent AF was arbitrarily set to 30 s.
2
7e decided to take this widely used definition to allow
omparison with other AF studies. If the definition of AF is
hanged to 15 s, only one additional patient had recur-
ence of AF because the vast majority of atrial runs were of
hort duration (median duration 1.2 s). Therefore, results
ould not differ substantially if this shorter duration had
een chosen.
AC and atrial runs in patients with and without reoc-
urrence of AF. Comparing patients without (n 26) and
atients with AF recurrences (n  4, 3 with former
ersistent AF), PACs were more frequent in patients with
F recurrences: median 13,560 (range 726 to 62,751) versus
edian 199 (range 10 to 32,568). Accordingly, patients
ith AF recurrences had more atrial runs: median 131
range 7 to 321) versus median 7 (range 0 to 83) in patients
ithout AF recurrence.
ymptoms. Patients with only PACs and atrial runs scored
heir symptoms as none in 68% (n 17), as minimal in 24%
n  6), and as mild in 8% (n  2). No patient had
oderate or severe symptoms. One patient did not state his
ymptoms on the symptom log. Patients with AF recurrence
n  4) scored their symptoms as none (n  1), mild (n 
), moderate (n  1), and severe (n  1). Sixty-one percent
f all asymptomatic patients were treated with beta-
igure 4. Freedom from atrial fibrillation (AF) in all patients and in those
ith former paroxysmal (n  17) and persistent (n  13) AF after 3.6 
.4 years.
igure 5. Freedom from atrial fibrillation (AF) after the procedure and
fter 6 months and 1, 2, and 3 years, respectively. Follow-up was done by
ontinuous monitoring during the first week after ablation, conventional
4-h electrocardiogram (ECG) after 6 months and 1 and 2 years, and
-day ECG after 3 years.
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Trigger Activity Late After Ablation of AF July 19, 2005:338–43lockers, whereas 73% of all symptomatic patients (minimal
o severe symptoms) had beta-blocker treatment.
ISCUSSION
ain findings. The present study shows, for the first time,
hat trigger activity late after specific linear LA ablation
emains present in the majority of patients. Premature atrial
omplexes were found in all patients. Atrial runs (3 beats up
o 30 s) were frequent but of short duration (median 1.2 s).
ole of trigger activity after catheter ablation. For cura-
ive treatment of AF, the initiating triggers and the perpet-
ating substrate are the main targets for interventional
blation strategies (1–6). The majority of foci triggering AF
riginate from myocardial sleeves within the PVs. Addi-
ionally, foci were found in the funnel-shaped transition
one and, in some cases, also in areas of the left or right
trium unrelated to the PVs (1,9–11).
Electrophysiologic studies in patients undergoing repeat
V isolation because of AF recurrences showed that in the
ajority of cases reinitiating triggers originate from previ-
usly isolated PVs, which have regained conduction to the
A (12,13). To date, no reports on the presence of ectopic
ctivity and atrial runs after successful PV isolation targeting
rigger elimination are present during long-term follow-up.
ccordingly, it is unknown whether trigger activity remains
resent in the long-term follow-up after LA linear ablation
argeting at the perpetuation of AF without PV isolation.
The prevention of the perpetuating re-entrant circuits as
ubstrate modification is the alternative interventional treat-
ent strategy to cure AF.
In the IRAAF study, a specific LA linear lesion concept
argeting at the prevention of anatomic LA re-entry was
ested using intraoperative ablation with minimally invasive
urgical techniques (7,8). In that study, contiguous RF
nergy-induced lesion lines involving the MA and the
rifices of the PVs were placed under direct vision to
revent anatomically defined LA re-entrant circuits.
The present study analyzed the occurrence and role of
rigger activity late after substrate modification in patients
ith paroxysmal and persistent AF treated with the IRAAF
oncept. Continuous digital seven-day ECGs were used for
ollow-up. With this approach, significantly more AF epi-
odes could be detected compared with conventional 24-h
CG in a recent study using percutaneous ablation (14).
The quantitative analysis of atrial ectopy and in particular
trial runs, defined as runs of atrial tachycardia/
onsustained AF episodes from 3 beats up to 30 s, showed
he presence of PAC in all patients and frequent PAC and
trial runs in the majority of patients. The median duration
f ventricular contractions resulting from atrial runs was
ow, measuring 1.2 s/run with a median number of 4
entricular contractions per atrial run. Whether all PACs
nd atrial runs represent potential triggers for induction of
F remains unproven, because their origin was not deter-
ined invasively and their role in inducing AF beforeblation cannot be quantified. However, despite the high
revalence of atrial ectopy, the rate of AF recurrence was
ow (4 of 30 patients, 13%) both in patients with paroxysmal
F (1 of 17 patients, 6%) and in those with former
ersistent AF (3 of 13 patients, 23%). This implies that with
his strategy aiming at the perpetuation of AF, the substrate
annot sustain AF in the majority of patients.
tudy limitations. Atrial ectopy was found in all patients,
nd atrial runs were found in 83% of patients. However, the
igh use of beta-blockers in our study cohort may have
nfluenced the amount and occurrence of PACs and atrial
uns, which might have been even higher without this
reatment. In addition, beta-blockade may have influenced
he high percentage of asymptomatic or only mildly symp-
omatic patients.
Measurement of trigger activity in one-lead surface ECG
s a surrogate of trigger activity measured invasively, and the
rigin within the atria cannot be determined. However,
rigger activity is likely underestimated by seven-day ECG
ecause of AV block and hidden P waves in the T waves and
T-segment, and because of non-conducted ectopic activity
rom the foci to atrial musculature. Moreover, trigger
ctivity has a wide time-dependent intra-individual and
nterindividual variability, which underlines the usefulness
f long-term recordings such as the continuous seven-day
CG recordings that were used in the present study.
nalysis with larger sample size would be desirable to
onfirm our results.
eprint requests and correspondence: Dr. Hildegard Tanner,
niversity of Leipzig, Heart Center, Cardiology, Dept. of Elec-
rophysiology, Struempellstrasse 39, D-04289 Leipzig, Germany.
-mail: hilditanner@pop.agri.ch.
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